The Eli Lilly collaboration marks one of the largest generative AI-driven partnerships in the pharmaceutical industry to date ...

New criteria show how arthralgia symptoms and biomarkers may help predict rheumatoid arthritis risk earlier in care. Read more.

War-related disruptions to major global transport routes in the Middle East are delaying the delivery of life-saving care for women and girls. Read more.

Type D personality was linked to lower adherence and more side-effects in bilevel positive airway pressure therapy for sleep apnoea patients.

A novel cell-free therapy restored hair growth, improved follicle structure, and showed no toxicity in preclinical models. Read more.

Major trial finds no cognitive function benefit from exercise or vascular risk reduction in older adults at risk of dementia. Click to learn more.

An emerging and “highly divergent” SARS-CoV-2 variant has now been reported in 23 countries since first detection in November 2024. Read more.

Delgocitinib vs PUVA shows comparable efficacy in chronic hand eczema with QoL benefits. Find out more about this real-world study.

Oestrogen-induced DNA damage drives genomic instability in BRCA1 mutation cells, with dietary compounds showing protective potential.

Italian health authorities have been alerted of the first human case of avian influenza A(H9N2) in the EU. Read more.

Can muscle stiffness predict stroke recovery? Read more about trunk control findings in acute stroke survivors.

PATIENTS with moderate-to-severe atopic dermatitis showed generally low long-term upadacitinib safety event rates across ages. Upadacitinib Safety in Atopic Dermatitis Across Age ...